AVGO vs CACI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
CACI exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. While the current price of $516.54 is significantly above the defensive Graham Number ($313.75), it trades at a substantial discount to its growth-based intrinsic value of $688.83 and analyst targets. Despite bearish short-term technicals and insider selling, the company's consistent track record of earnings beats and double-digit EPS growth support a long-term bullish outlook.
Compare Another Pair
Related Comparisons
AVGO vs CACI: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and CACI International Inc (CACI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.